Corey Davis
Stock Analyst at HC Wainwright & Co.
(3.00)
# 1,498
Out of 5,090 analysts
17
Total ratings
75%
Success rate
25.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $480 → $390 | $56.90 | +585.41% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.66 | +7,526.60% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $27.35 | +46.25% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $3.15 | +5,296.83% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $5.39 | +271.06% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $23.99 | +108.42% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $169.70 | -15.14% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $480 → $390
Current: $56.90
Upside: +585.41%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.66
Upside: +7,526.60%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $27.35
Upside: +46.25%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $3.15
Upside: +5,296.83%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $5.39
Upside: +271.06%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $23.99
Upside: +108.42%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $169.70
Upside: -15.14%